Jonathan H. Marks's guest appearances

Jonathan H. Marks

Give and Take

Leonard Lopate at Large on WBAI Radio in New York

Thane Rosenbaum

Lee McIntyre

Katherine Stewart

Barbara Freese

David Gessner

Bob Holman

Nicholas Buccola

Donald Trump

Ben Cohen

Karen Cooper

Dan White Jr

Adam Hamilton

Rob Bell

Jamie Wright

Jonathan Merritt

OwlTail

My guest is Jonathan H. Marks. His new book is The Perils of Partnership: Industry Influence, Institutional Integrity, and Public Health. Countless public health agencies are trying to solve our most intractable public health problems -- among them, the obesity and opioid epidemics -- by partnering with corporations responsible for creating or exacerbating those problems. We are told industry must be part of the solution. But is it time to challenge the partnership paradigm and the popular narratives that sustain it?  In The Perils of Partnership, Jonathan H. Marks argues that public-private partnerships and multi-stakeholder initiatives create "webs of influence" that undermine the integrity of public health agencies; distort public health research and policy; and reinforce the framing of public health problems and their solutions in ways that are least threatening to the commercial interests of corporate "partners". We should expect multinational corporations to develop strategies of influence -- but public bodies can and should develop counter-strategies to insulate themselves from corporate influence in all its forms. Marks reviews the norms that regulate public-public interactions (separation of powers) and private-private interactions (antitrust and competition law), and argues for an analogous set of norms to govern public-private interactions. He also offers a novel framework to help public bodies identify the systemic ethical implications of their current or proposed relationships with industry actors.  Marks makes a compelling case that the default public-private interaction should be at arm's length: separation, not collaboration. He calls for a new paradigm that avoids the perils of corporate influence and more effectively protects and promotes public health. The Perils of Partnership is essential reading for public health officials and policymakers -- but anyone interested in public health will recognize the urgency of this book. Special Guest: Jonathan H. Marks.

My guest is Jonathan H. Marks. His new book is <a href="https://www.amazon.com/Perils-Partnership-Influence-Institutional-Integrity/dp/0190907088/ref=tmm_hrd_swatch_0?_encoding=UTF8&amp;qid=&amp;sr=" rel="nofollow" target="_blank">The Perils of Partnership: Industry Influence, Institutional Integrity, and Public Health</a>. Countless public health agencies are trying to solve our most intractable public health problems -- among them, the obesity and opioid epidemics -- by partnering with corporations responsible for creating or exacerbating those problems. We are told industry must be part of the solution. But is it time to challenge the partnership paradigm and the popular narratives that sustain it? In <a href="https://www.amazon.com/Perils-Partnership-Influence-Institutional-Integrity/dp/0190907088/ref=tmm_hrd_swatch_0?_encoding=UTF8&amp;qid=&amp;sr=" rel="nofollow" target="_blank">The Perils of Partnership,</a> Jonathan H. Marks argues that public-private partnerships and multi-stakeholder initiatives create "webs of influence" that undermine the integrity of public health agencies; distort public health research and policy; and reinforce the framing of public health problems and their solutions in ways that are least threatening to the commercial interests of corporate "partners". We should expect multinational corporations to develop strategies of influence -- but public bodies can and should develop counter-strategies to insulate themselves from corporate influence in all its forms. Marks reviews the norms that regulate public-public interactions (separation of powers) and private-private interactions (antitrust and competition law), and argues for an analogous set of norms to govern public-private interactions. He also offers a novel framework to help public bodies identify the systemic ethical implications of their current or proposed relationships with industry actors. Marks makes a compelling case that the default public-private interaction should be at arm's length: separation, not collaboration. He calls for a new paradigm that avoids the perils of corporate influence and more effectively protects and promotes public health. The Perils of Partnership is essential reading for public health officials and policymakers -- but anyone interested in public health will recognize the urgency of this book. Special Guest: Jonathan H. Marks.

Episode 158: The Perils of Partnership, with Jonathan H. Marks

According to the CDC, between 1999 and 2017 over 218,000 Americans died due to overdoses from prescription opioids--more than 3 times the number of Americans killed in Vietnam. A current Massachusetts court case alleges that Purdue Pharmaceuticals, the multi-billion dollar company that makes Oxycontin, continued to “turbocharge” sales of the drug while downplaying its extreme danger--for more than a decade after pleading guilty in 2007 to misleading regulators, doctors, and patients about the drug’s risk of addiction and potential for abuse. And yet in 2017, when the National Institutes of Health held meetings to combat the crisis, they turned to…Purdue executives for advice. This would be darkly comic if so many lives were not at stake—and the practice was not so common. Building on the ideas in his popular TED talk “In Praise of Conflict,” Jonathan H. Marks examines the widespread practice of public-private partnerships in “The Perils of Partnership: Industry Influence, Institutional Integrity, and Public Health.” Join us on “Leonard Lopate at Large” on WBAI for a conversation with Jonathan H. Marks about why this troubling practice needs to stop.

Jonathan H. Marks talks about the dangers of public-private partnerships. (3/15/19)